Addex Therapeutics Ltd ADR (ADXN) Stock Price, Quote & News

Company Profile

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate re...

Industry: Biotechnology

Sector: Healthcare

Phone: 41 22 884 1555

Fax: 41 22 884 1556

Website: www.addextherapeutics.com

Address:

Chemin des Mines, 9, Geneva, Switzerland

MarketClarityX Dec. 27 at 6:27 AM

$ADXN Investor attention is skewing toward repeatable operating performance instead of aspirational projections. Resource allocation choices will signal strategic maturity. Transparency improvements could narrow valuation spreads. As performance stabilizes, the path forward can strengthen.

0 · Reply

ALRAE Dec. 22 at 1:32 AM

0 · Reply

P4antomDock_144 Dec. 20 at 8:34 PM

$ADXN small biotech name, if it keeps carving higher lows a catalyst plus volume can turn this sleepy base into a squeeze

0 · Reply

GammaFocus_1776 Dec. 17 at 11:01 AM

$ADXN small biotech grinding sideways, need a higher low and expanding volume to prove this is accumulation not drift

0 · Reply

flybyme Dec. 12 at 9:55 AM

$ADXN Where have all the pumpers gone, they will be back in a coupel of months, as always.

0 · Reply

flybyme Dec. 11 at 3:34 PM

$ADXN more dilution on nothing https://www.addextherapeutics.com/en/investors/press-releases/addex-amends-its-market-offering-agreement-hc-wainwright-co/

0 · Reply

ClassifiedTrades Dec. 1 at 1:56 PM

$AHMA 11.80 hit ! $QTTB $ADXN

0 · Reply

Alflong1 Dec. 1 at 1:20 PM

$ADXN hope today is the day!!!

0 · Reply

topstockalerts Nov. 24 at 9:37 PM

After Hours Top Gainers $ICON $GP.X $JFIN $PTIX $ADXN

0 · Reply

flybyme Nov. 24 at 3:56 PM

$ADXN i put this in here a while back, do some DD and you will see the Gem NWPHF ADDEX is a snooze fest ,has been for years

0 · Reply

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

Dec 4, 2025, 1:38 PM EST - 23 days ago

Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript

Dec 4, 2025, 1:00 AM EST - 24 days ago

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Dec 1, 2025, 1:00 AM EST - 27 days ago

Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025

Oct 1, 2025, 1:52 PM EDT - 3 months ago

Addex Therapeutics Ltd (ADXN) Q2 2025 Earnings Call Transcript

Sep 30, 2025, 1:00 AM EDT - 3 months ago

Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 26, 2025, 1:00 AM EDT - 3 months ago

Addex Therapeutics to Report 2025 Half-year and Second Quarter Financial Results on September 30, 2025 and Host Conference Call on October 1, 2025

Sep 23, 2025, 1:00 AM EDT - 3 months ago

Addex Appoints Bank of New York Mellon as Depositary Bank

Jun 30, 2025, 1:00 AM EDT - 6 months ago

Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs

Jun 30, 2025, 1:00 AM EDT - 6 months ago

Addex Leads CHF 2 Million Investment in Stalicla to Advance Precision Medicine in Neuropsychiatric Disorders

Jun 25, 2025, 1:00 AM EDT - 6 months ago

Addex Shareholders Approve All Resolutions at Annual General Meeting

Jun 19, 2025, 1:00 AM EDT - 6 months ago

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

Jun 18, 2025, 1:00 AM EDT - 6 months ago

Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025

Jun 6, 2025, 1:00 AM EDT - 7 months ago

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models

Jun 3, 2025, 1:00 AM EDT - 7 months ago

Addex Convenes Annual General Meeting 2025

May 12, 2025, 1:00 AM EDT - 8 months ago

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Apr 30, 2025, 1:00 AM EDT - 8 months ago

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

Apr 25, 2025, 4:40 PM EDT - 8 months ago

Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript

Apr 25, 2025, 1:00 AM EDT - 8 months ago

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

Apr 17, 2025, 1:00 AM EDT - 9 months ago

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

Jan 8, 2025, 1:00 AM EST - 1 year ago

Addex to Present at the 2025 Swiss Equities Baader Conference

Nov 22, 2024, 11:11 AM EST - 1 year ago

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript

Nov 22, 2024, 1:00 AM EST - 1 year ago

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 11, 2024, 1:00 AM EST - 1 year ago

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Sep 30, 2024, 12:04 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript

Sep 30, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Sep 19, 2024, 1:00 AM EDT - 1 year ago

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Sep 4, 2024, 1:00 AM EDT - 1 year ago

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 12:03 PM EDT - 1 year ago

Crude Oil Dips; Addex Therapeutics Shares Spike Higher

Aug 27, 2024, 10:47 AM EDT - 1 year ago

Why Addex Therapeutics stock skyrocketed 70% on Tuesday

Aug 27, 2024, 1:00 AM EDT - 1 year ago

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Jul 22, 2024, 1:00 AM EDT - 1 year ago

Addex's Partner Discontinues ADX71149 development in Epilepsy

Jul 15, 2024, 1:00 AM EDT - 1 year ago

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Jul 12, 2024, 1:00 AM EDT - 1 year ago

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Jun 6, 2024, 12:50 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript

Jun 6, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update

Jun 5, 2024, 1:00 AM EDT - 1 year ago

Addex Convenes Annual General Meeting 2024

May 31, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

May 8, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at Bio€quity Europe 2024

Apr 29, 2024, 1:00 AM EDT - 1 year ago

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Apr 19, 2024, 1:00 AM EDT - 1 year ago

Addex to Present at the Swiss Biotech Day 2024

Apr 18, 2024, 1:46 PM EDT - 1 year ago

Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript

Apr 18, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update

Apr 11, 2024, 1:00 AM EDT - 1 year ago

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Apr 3, 2024, 1:00 AM EDT - 1 year ago

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Mar 14, 2024, 2:00 AM EDT - 1 year ago

Addex to Present at the Bio-Europe Spring 2024 Conference

Jan 31, 2024, 1:00 AM EST - 2 years ago

Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

Jan 9, 2024, 1:00 AM EST - 2 years ago

Addex to Present at the Swiss Equities Baader Conference

Jan 5, 2024, 1:30 AM EST - 2 years ago

Addex to Present at Biotech Showcase™ 2024

Dec 20, 2023, 1:00 AM EST - 2 years ago

Addex Shareholders Approve All Resolutions at Extraordinary General Meeting

MarketClarityX Dec. 27 at 6:27 AM

0 · Reply

ALRAE Dec. 22 at 1:32 AM

0 · Reply

P4antomDock_144 Dec. 20 at 8:34 PM

$ADXN small biotech name, if it keeps carving higher lows a catalyst plus volume can turn this sleepy base into a squeeze

0 · Reply

GammaFocus_1776 Dec. 17 at 11:01 AM

$ADXN small biotech grinding sideways, need a higher low and expanding volume to prove this is accumulation not drift

0 · Reply

flybyme Dec. 12 at 9:55 AM

$ADXN Where have all the pumpers gone, they will be back in a coupel of months, as always.

0 · Reply

flybyme Dec. 11 at 3:34 PM

$ADXN more dilution on nothing https://www.addextherapeutics.com/en/investors/press-releases/addex-amends-its-market-offering-agreement-hc-wainwright-co/

0 · Reply

ClassifiedTrades Dec. 1 at 1:56 PM

$AHMA 11.80 hit ! $QTTB $ADXN

0 · Reply

Alflong1 Dec. 1 at 1:20 PM

$ADXN hope today is the day!!!

0 · Reply

topstockalerts Nov. 24 at 9:37 PM

After Hours Top Gainers $ICON $GP.X $JFIN $PTIX $ADXN

0 · Reply

flybyme Nov. 24 at 3:56 PM

$ADXN i put this in here a while back, do some DD and you will see the Gem NWPHF ADDEX is a snooze fest ,has been for years

0 · Reply

Alflong1 Nov. 20 at 3:53 PM

$ADXN finally volume!!! Only problem is that it’s moving the wrong way

0 · Reply

topstockalerts Nov. 19 at 9:31 PM

After Hours Top Gainers PT2 $ENVB $HXHX $RPGL $MIGI $ADXN

0 · Reply

Alflong1 Nov. 13 at 4:29 PM

$ADXN ok we got movement!!! Let’s go!!!

0 · Reply

PIGMONKEYTV Nov. 12 at 3:31 PM

$ADXN finding the quiet places, buying, and waiting.. hasnt failed yet..

0 · Reply

Alflong1 Nov. 12 at 2:41 PM

$ADXN 3rd straight day of minimal volume. So frustrating!!

0 · Reply

Alflong1 Nov. 10 at 6:04 PM

$ADXN no volume at all!! Delisting!

1 · Reply

BenKaitz Nov. 5 at 6:14 PM

$ADXN seven potential partnership announcements and three expected positive catalysts in the next couple months:

1 · Reply

BenKaitz Nov. 5 at 6:13 PM

$ADXN

0 · Reply

Eliza1 Nov. 3 at 9:04 PM

$ADXN wow. I would hate to be short this stock right now. Get ready for a big move up this week. JMHO

0 · Reply

Eliza1 Oct. 31 at 9:55 PM

$ADXN I repeat the below. We are getting closer to that point. I prefer a PR and a 7 am opening of $75+... Good Luck!

0 · Reply

Eliza1 Oct. 29 at 1:20 PM

$ADXN stocks have been flying on similar news. If you read the article-the number of shares outstanding does not change. So, NO MORE SHARES.

1 · Reply

flybyme Oct. 29 at 8:53 AM

$ADXN so more Shares https://www.addextherapeutics.com/en/investors/press-releases/addex-increases-issued-share-capital-create-treasury-shares4/

0 · Reply

Market Cap	9.84M
Revenue (ttm)	460,000.00
Net Income (ttm)	8.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	1,741.30%
Debt to Equity Ratio	0.00

Volume	3,000
Avg Vol	12,786
Day's Range	N/A - N/A
Shares Out	1.23M
Stochastic %K	52%
Beta	1.57
Analysts	Strong Buy
Price Target	$30.00